iThe current values are delayed, open demat account for live values.
Nifty Pharma
Nifty Pharma Performance
-
Open
20,824.70
-
High
20,869.10
-
Low
20,303.35
-
Prev Close
20,785.75
-
Dividend Yeild
0.67%
-
P/E
31.42
Nifty Pharma Chart


Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
Company | Market Cap | Market Price | Volume | Sector |
---|---|---|---|---|
Abbott India Ltd | ₹61506 Cr |
₹29000
(1.42%)
|
12948 | Pharmaceuticals |
Cipla Ltd | ₹119067 Cr |
₹1475.75
(0.88%)
|
1911268 | Pharmaceuticals |
J B Chemicals & Pharmaceuticals Ltd | ₹24982 Cr |
₹1606.85
(0.76%)
|
179534 | Pharmaceuticals |
Dr Reddys Laboratories Ltd | ₹96124 Cr |
₹1151.8
(0.69%)
|
2215205 | Pharmaceuticals |
Lupin Ltd | ₹87012 Cr |
₹1905.35
(0.42%)
|
947831 | Pharmaceuticals |
Nifty Pharma Sector Performance
Top Performing
Sector Name | Percentage Change |
---|---|
Ceramic Products | 0.01 |
Dry cells | 2.46 |
Real Estate Investment Trusts | 0.52 |
Paints/Varnish | 0.6 |
Under Performing
Sector Name | Percentage Change |
---|---|
Diamond, Gems and Jewellery | -1.56 |
IT - Hardware | -0.49 |
Leather | -0.67 |
Healthcare | -0.4 |
Nifty Pharma
Nifty Pharma index is a stock market index that tracks the performance of the top pharmaceutical companies listed on National Stock Exchange in India. It includes companies involved in the development, manufacturing, and marketing of drugs and healthcare products. Investors use Nifty Pharma index to gauge the health of the pharmaceutical sector and to make investment decisions. A rising index indicates strong performance by these companies while a falling index might signal challenges or weaker performance in the sector. It's a key indicator for those interested in the Indian pharmaceutical industry.
NIFTY Pharma Index was launched on 1 July 2005 and initially included only 10 stocks. Since 30 September 2021, it has expanded to 20 tradable pharmaceutical stocks listed on the exchange. NIFTY Pharma index includes companies involved in biotechnology and pharmaceuticals. It is rebalanced twice a year to reflect changes in the Indian healthcare industry. Managed by NSE Indices Limited formerly India Index Services & Products Limited, the index is overseen by a three tier system Board of Directors, Index Advisory Committee and Index Maintenance Sub Committee. Additionally, there is a variant called NIFTY Pharma Total Returns Index.
What is the Nifty Pharma Index?
NIFTY Pharma Index launched on 1 July 2005 tracks the performance of the pharmaceutical sector in India. Initially comprising 10 stocks, it expanded to 20 tradable stocks from 30 September 2021. NIFTY Pharma index includes companies involved in biotechnology and pharmaceuticals. It started with a base value of 1000 based on 1 January 2001. Managed by NSE Indices Limited, the index is updated semi annually to reflect changes in the healthcare industry. There is also a variant, the NIFTY Pharma Total Returns Index.
How is the Nifty Pharma Index Value Calculated?
Nifty Pharma Index value is calculated using the formula
Index Value = Current Market Capitalization / (Base Market Capitalization * Base Index Value).
This index is updated twice a year with adjustments based on data up to 31 January and 31 July. If there are changes in the companies included in the index these are announced four weeks in advance and take effect on the last trading day of March and September. This process ensures the index accurately reflects the performance of leading pharmaceutical companies in the market.
Nifty Pharma Scrip Selection Criteria
Nifty Pharma Index is made up of 20 pharmaceutical stocks, chosen based on their market value adjusted for how freely their shares are traded. To be included, a stock must meet several criteria:
1. It must be listed on National Stock Exchange.
2. It must be part of Nifty 500 index.
3. If there aren't enough eligible stocks, additional ones are picked from the top 800 stocks based on trading activity and market value from Nifty 500 list.
4. It must be from the pharmaceutical sector.
5. It should have traded at least 90% of the time over the past six months.
6. It must have been listed for at least six months.
7. Ideally, it should be traded on NSE’s Futures & Options segment.
8. Newly listed companies can be included if they meet these criteria for at least three months.
9. No single stock should make up more than 33% of the index and top three stocks combined should not exceed 62% of the index.
How does Nifty Pharma work?
Nifty Pharma is an index on National Stock Exchange that tracks the performance of major pharmaceutical companies in India. It includes top pharma stocks based on market capitalization and liquidity. Nifty Pharma index reflects the overall health of the pharmaceutical sector, showing how well these companies are performing. Investors use it to gauge sector trends, make investment decisions and compare the performance of individual pharma stocks against the broader market. When the index goes up, it means the pharma sector is doing well and vice versa.
What are the Benefits of Investing in the Nifty Pharma?
Investing in Nifty Pharma index offers several benefits. It provides exposure to leading pharmaceutical companies in India allowing you to tap into the growing healthcare sector. Nifty Pharma index includes firms with strong fundamentals and consistent performance. By investing in Nifty Pharma, you gain diversification within the pharma sector reducing the risk associated with individual stocks. Additionally, the pharmaceutical industry usually benefits from increasing healthcare demands and advancements in medical technology, potentially leading to steady returns. This makes Nifty Pharma a promising option for those looking to invest in a crucial and expanding sector.
What is the History of the Nifty Pharma?
NIFTY Pharma index launched on 1 July 2005 with a base value of 1000 from 1 January 2001, tracks major pharmaceutical companies in India. As of September 2024 Nifty Pharma Index current price is 23,256.85. It’s updated twice a year to stay current with the pharmaceutical industry's changes. Managed by NSE Indices Limited, Nifty pharma index has a governance structure that includes a Board of Directors, Advisory Committee and a Maintenance Sub Committee. There's also a variant called NIFTY Pharma Total Returns Index.
Other Indices
Indices Name | Price | Price Change (% change) |
---|---|---|
India VIX | 14.53 | -0.15 (-1.02%) |
Nifty 10 Yr Benchmark G-Sec | 2477.38 | -3.81 (-0.15%) |
Nifty 10 Yr Benchmark G-Sec (Clean Price) | 893.06 | -1.58 (-0.18%) |
Nifty 100 | 23274.05 | -137.35 (-0.59%) |
Nifty 100 Alpha 30 Index | 16085.8 | -230.85 (-1.41%) |
Faqs
How To Invest in Nifty Pharma Stocks?
You can invest in the NIFTY Pharma index through various methods:
1. Direct Investment: Use a trading account to buy individual stocks from the NIFTY Pharma index.
2. Exchange Traded Derivatives: Engage in futures and options contracts based on NIFTY Pharma index.
3. Exchange Traded Funds: ETFs aim to replicate the total returns of the NIFTY Pharma index accounting for tracking errors.
4. Index Mutual Funds: Some mutual funds focus on pharmaceutical companies and track the index though they may have high expense ratios.
What are Nifty pharma stocks?
Nifty Pharma stocks are shares of major pharmaceutical companies listed on NIFTY Pharma index. These companies are selected for their role in India's pharma sector, reflecting their impact on the industry's performance and growth. Examples include Sun Pharma, Dr. Reddy's Laboratories and Cipla.
Can you trade shares on Nifty Pharma?
Yes, you can trade shares of companies listed in the Nifty Pharma Index through a Demat account. You can also invest in ETFs or index funds that track the index for broader exposure to the Pharma sector.
In which year was the Nifty Pharma Index launched?
Nifty Pharma Index was launched on 1 July 2005 by NSE Indices Limited to track the performance of India's Pharma sector.
Can we buy Nifty Pharma and sell it tomorrow?
Yes, you can buy Nifty Pharma stocks and sell them the next day, following the BTST (Buy Today, Sell Tomorrow) strategy. This allows you to take advantage of short term price movements without waiting for the usual settlement period.
Latest News

- Feb 21, 2025
Indian stock markets ended in the red as key indices faced pressure from auto and financial stocks. The Sensex fell 424 points to close at 75,311, while the Nifty slipped 117 points to end at 22,795. The sell-off was led by the auto sector, which tanked 2.5% following reports of a potential reduction in import duties on EVs.

- Feb 21, 2025
The ownership structure of India Inc. is experiencing a significant transformation, with foreign portfolio investors (FPIs) reaching their lowest stake in NSE-listed companies in 13 years. In contrast, domestic mutual funds (MFs) and retail investors are making substantial gains.

- Feb 21, 2025
Amid reports of senior executives departing Tata Motors Ltd. ahead of its planned demerger, the company’s stock faced significant selling pressure during Friday’s early trading session. Tata Motors' share price opened lower at ₹686 per share on the NSE and quickly dropped to an intraday low of ₹673.30 within the first hour of trading.

- Feb 21, 2025
Regulated entities must cultivate the necessary capabilities to adapt to and adhere to evolving regulations, stated Rajeshwar Rao, deputy governor of the Reserve Bank of India (RBI), on February 21. As financial institutions increasingly adopt artificial intelligence (AI), cloud computing, and API-driven finance, the demand for strong governance frameworks and risk management strategies has never been more critical, he noted.
Latest Blogs
Introduction to Ashish Kacholia Ashish Kacholia's financial journey began in the 1990s. He gained valuable experience at firms like Prime Securities and Edelweiss before founding Lucky Securities in 1995. In 1999, he co-founded Hungama Digital with Rakesh Jhunjhunwala, showcasing his ability to spot emerging trends.
- Oct 10, 2025

Navigating the numerous banking options in India is essential for individuals and businesses alike. The best banks in India go beyond traditional banking, offering a wide array of financial services that play a crucial role in the country's economic stability. From innovative digital banking solutions to comprehensive investment and loan offerings, these famous banks in India serve as reliable financial partners.
- Apr 14, 2025


Nifty Prediction for 24th February Another weak day for the NIFTY as it falls 0.6% and closes marginally below 22800. Auto stocks corrected sharply on concerns over a new EV policy that could increase competition. M&M was the top loser at -6%. TATAMOTORS also corrected 2.5%. ADANIPORTS AND WIPRO were among the other top losers. On the other hand, HINDALCO, SBILIFE AND TATASTEEL bucked the trend and were up 2-2.5%. ADR was weak at 0.3 and indicates a broadbased correction.
- Feb 21, 2025
